PMC:7441788 / 17675-18682
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T108 | 868-871 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T109 | 902-925 | Body_part | denotes | upper respiratory tract | http://purl.org/sig/ont/fma/fma45661 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T8 | 902-925 | Body_part | denotes | upper respiratory tract | http://purl.obolibrary.org/obo/UBERON_0001557 |
| T9 | 908-925 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T102 | 296-304 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T180 | 22-27 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T181 | 343-344 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T226 | 22-27 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T227 | 61-66 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T228 | 84-89 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T229 | 361-366 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T230 | 538-547 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T9 | 412-424 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | investigator | http://purl.bioontology.org/ontology/MEDDRA/10062026 |
| T10 | 938-960 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | bronchoalveolar lavage | http://purl.bioontology.org/ontology/MEDDRA/10049413 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T136 | 868-871 | Chemical | denotes | RNA | http://purl.obolibrary.org/obo/CHEBI_33697 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T104 | 296-304 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T131 | 0-16 | Sentence | denotes | Tang et al [54]. |
| T132 | 17-98 | Sentence | denotes | Open label, randomized controlled trial HCQ group: n = 70; control group: n = 80. |
| T133 | 99-305 | Sentence | denotes | HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. |
| T134 | 306-334 | Sentence | denotes | Randomized controlled study. |
| T135 | 335-533 | Sentence | denotes | Lack of a placebo control group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. |
| T136 | 534-717 | Sentence | denotes | The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to severe, and the effect of HCQ on disease progression or regression could not be provided. |
| T137 | 718-794 | Sentence | denotes | The trial terminated early due to the difficulty to recruit enough patients. |
| T138 | 795-1007 | Sentence | denotes | Some secondary endpoints could not be analyzed by the cutoff date; Viral RNA specimens are mostly from the upper respiratory tract rather than bronchoalveolar lavage fluid, which may cause false negative results. |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T8 | 902-925 | Body_part | denotes | upper respiratory tract | http://purl.obolibrary.org/obo/UBERON_0001557 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 644 | 265-273 | Species | denotes | patients | Tax:9606 |
| 645 | 607-615 | Species | denotes | patients | Tax:9606 |
| 646 | 785-793 | Species | denotes | patients | Tax:9606 |
| 671 | 57-60 | Chemical | denotes | HCQ | MESH:D006886 |
| 672 | 99-102 | Chemical | denotes | HCQ | MESH:D006886 |
| 673 | 205-208 | Chemical | denotes | HCQ | MESH:D006886 |
| 674 | 560-563 | Chemical | denotes | HCQ | MESH:D006886 |
| 675 | 654-657 | Chemical | denotes | HCQ | MESH:D006886 |
| 711 | 296-304 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T118 | 172-179 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
| T119 | 196-203 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
| T120 | 538-547 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
| T121 | 661-668 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T107 | 868-871 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T108 | 902-925 | Body_part | denotes | upper respiratory tract | http://purl.org/sig/ont/fma/fma45661 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T95 | 296-304 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T60 | 984-989 | http://purl.obolibrary.org/obo/GO_0071878 | denotes | false |
| T61 | 984-989 | http://purl.obolibrary.org/obo/GO_0071877 | denotes | false |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 644 | 265-273 | Species | denotes | patients | Tax:9606 |
| 645 | 607-615 | Species | denotes | patients | Tax:9606 |
| 646 | 785-793 | Species | denotes | patients | Tax:9606 |
| 671 | 57-60 | Chemical | denotes | HCQ | MESH:D006886 |
| 672 | 99-102 | Chemical | denotes | HCQ | MESH:D006886 |
| 673 | 205-208 | Chemical | denotes | HCQ | MESH:D006886 |
| 674 | 560-563 | Chemical | denotes | HCQ | MESH:D006886 |
| 675 | 654-657 | Chemical | denotes | HCQ | MESH:D006886 |
| 711 | 296-304 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T131 | 0-16 | Sentence | denotes | Tang et al [54]. |
| T132 | 17-98 | Sentence | denotes | Open label, randomized controlled trial HCQ group: n = 70; control group: n = 80. |
| T133 | 99-305 | Sentence | denotes | HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19. |
| T134 | 306-334 | Sentence | denotes | Randomized controlled study. |
| T135 | 335-533 | Sentence | denotes | Lack of a placebo control group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. |
| T136 | 534-717 | Sentence | denotes | The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to severe, and the effect of HCQ on disease progression or regression could not be provided. |
| T137 | 718-794 | Sentence | denotes | The trial terminated early due to the difficulty to recruit enough patients. |
| T138 | 795-1007 | Sentence | denotes | Some secondary endpoints could not be analyzed by the cutoff date; Viral RNA specimens are mostly from the upper respiratory tract rather than bronchoalveolar lavage fluid, which may cause false negative results. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32496926-32409561-132195703 | 12-14 | 32409561 | denotes | 54 |